AstraZeneca’s Tagrisso (osimertinib) has been approved by the European Commission (EC) to treat a new subset of lung cancer patients. The epidermal growth factor receptor (EGFR)-tyrosine kinase ...

As the world’s third largest pharmaceutical market, Japan accounted for approximately 6% of the $1.5tn in global pharmaceutical sales in 2022. While this makes it an attractive market for all ...

Pfizer’s Braftovi (encorafenib) regimen has been granted accelerated approval by the US Food and Drug Administration (FDA) to treat metastatic colorectal cancer (mCRC). The drug has been authorised ...

For many years the pharma sector has been vocal in its commitment to a ‘patient-focused’ approach. As a result, there does seem to be more attention on the patient across med affairs, marketing and ...

Is your medical education strategy reaching the right HCPs in the formats they prefer? Discover actionable insights to elevate the impact of your medical education efforts in the latest Medical ...

Polymorphic Marketing Limited is a boutique marketing agency specialising in life science, biotechnology, laboratory consumables and scientific equipment marketing.

Step into the future of medical education with our exclusive webinar series from February 25-26, designed specifically for Pharma leaders. This transformative series will showcase the 2025 Pharma ...

Our aim is to provide both our clients and candidates with a focussed and supportive recruitment experience as well as offering a wealth of additional services. We are dedicated to revisiting ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a final call to marketing authorisation holders to ensure they are prepared to comply with the Windsor Framework arrangements ...

CHCR is a research centre offering healthcare communication consultancy, professional development and training including the first UK Postgraduate Certificate in Health Communications.

Our broad arsenal of services and solutions now spans the entire value chain. By expanding the methodologies of MarketRx, a highly respected firm acquired in 2007, our offerings now include: ...

Accession was a born from a passion and a vision. A passion to harness the power of market access to ensure patients gain access to life changing medicines and devices….